Rialto Wealth Management’s Avidity Biosciences RNAM Stock Holding History

Rialto Wealth Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8	Closed	-$578	–	1787
2025 Q4	$578	Buy	8 +7	+700%	+$452	﹤0.01%	1199
2025 Q3	$44	Buy	+1	New	+$40	﹤0.01%	1684

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Rialto Wealth Management's RNAM Position: Q1 2026 in Review

Rialto Wealth Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 8 shares — an estimated $578 sold.

Rialto Wealth Management first reported a position in RNAM in Q3 2025 and held it in 2 quarters. The position peaked at $578 in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Rialto Wealth Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Rialto Wealth Management sold 8 Avidity Biosciences shares in Q1 2026, an estimated $578.
Rialto Wealth Management first reported a position in Avidity Biosciences in Q3 2025 and held it in 2 quarters.
Rialto Wealth Management's Avidity Biosciences position peaked at $578 in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Rialto Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.